Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bcad4fa2e7550ad5af025b70c22fdcff7> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bcad4fa2e7550ad5af025b70c22fdcff7 NCIT_P378 "NCI" @default.
- Bcad4fa2e7550ad5af025b70c22fdcff7 type Axiom @default.
- Bcad4fa2e7550ad5af025b70c22fdcff7 annotatedProperty IAO_0000115 @default.
- Bcad4fa2e7550ad5af025b70c22fdcff7 annotatedSource NCIT_C2057 @default.
- Bcad4fa2e7550ad5af025b70c22fdcff7 annotatedTarget "A cell-based vaccine targets tumors expressing the HER2/neu marker. HER-2/neu is a growth factor receptor, and its overexpression has been associated with a number of cancers including breast, ovarian, colon and lung cancers. APC8024 comprise of autologous antigen-presenting peripheral blood mononuclear cells (APCs) that have been exposed to HER2/neu protein and can be administered to the patient. These cells may stimulate an antitumor T-cell response to cancer cells expressing HER2/neu. (NCI04)" @default.